CPHON Chemo UPDATED ACTUAL
Exam Questions and CORRECT
Answers
Which Chemo agent is associated with a high risk for hypersensitivity reaction?
A. Methotrexate
B. Carboplatin
C. Cytarabine
D. Busulfan - CORRECT ANSWER -B
Before a patient is to receive intrathecal Chemo:
A. Ensure developmentally appropriate patient teaching is completed
B. Verify the patient's white blood cell count
C. Ensure other chemo agents are available to administer
D. Apply LMX cream between L5-L7 - CORRECT ANSWER -A
John is a 3-year-old who is scheduled to receive his first subQ injection of Neupogen. What
would NOT be an appropriate strategy to decrease the pain associated with a SC injection?
A. Use of ice and insuflon catheter
B. Use of LMX cream
C. Use of distraction
D. Use of buffered lidocaine - CORRECT ANSWER -D
The preferred intramuscular site for a child wo is three-years-old and walks is:
,A. Deltoid muscle
B. Vastus lateralis muscle
C. Ventogluteal muscle
D. Dorsogluteal muscle - CORRECT ANSWER -A
Which statement best describes the nursing assessment for patency with a direct-push method of
administering a chemotherapy vesicant:
A. Assess for blood return before the infusion, every 2-5ml, and for blood return and pain at the
end of the infusion
B. Assess for blood return before the infusion and at the completion of the infusion
C. Assess for blood return before the infusion and for pain at the completion of the infusion
D. Assess for blood return before infusion, every 5-10ml, during the infusion, and at the end of
the infusion - CORRECT ANSWER -A
A strategy to prevent chemo errors includes:
A. Verification of patient's height in inches
B. Independent dose calculation
C. Use of full trade name of the drug
D. Use of abbreviations for drug clarification - CORRECT ANSWER -B
Which chemo agent is associated with a maximum cumulative lifetime dose?
A. Cyclophosphamide
B. Etoposide
C. Daunorubicin
D. Nitrogen mustard - CORRECT ANSWER -C
, After administering the first drug for a dermatologiv reaction after peg-Asparaginase, Sam starts
to complain of throat tightening and he starts wheezing. The MD orders Epiniphrine. What is the
preferred route?
A. PO
B. Sub-Q
C. IV
D. IM - CORRECT ANSWER -D
You are giving Doxorubicin peripherally IV push and based on the patient's complaints and loss
of blood return, you suspect that the Doxorubicin has extravasated. Your immediate nursing
intervention will involve:
A. SLAPP: Stop the infusion, leave the needle, aspirate as much drug as possible, pull the
needle, provider notification
B. SLAPP: Slow the infusion, leave the needle, attempt to flush, push the remainder of the flush
into the vein, pull the needle
C. STOP: Stop the infusion, treat the site, oncology team notification, provide follow up
D. STOP: Slow the infusion, treat the symptoms, oncology team notification, provide follow up -
CORRECT ANSWER -A
The immediate temperature application for a Doxorubicin/Daunorubicin extravasation involves:
A. Hot application
B. Warm application
C. Cold application
D. None of the above - CORRECT ANSWER -C
The primary goal of phase III clinical trials is to determine:
Exam Questions and CORRECT
Answers
Which Chemo agent is associated with a high risk for hypersensitivity reaction?
A. Methotrexate
B. Carboplatin
C. Cytarabine
D. Busulfan - CORRECT ANSWER -B
Before a patient is to receive intrathecal Chemo:
A. Ensure developmentally appropriate patient teaching is completed
B. Verify the patient's white blood cell count
C. Ensure other chemo agents are available to administer
D. Apply LMX cream between L5-L7 - CORRECT ANSWER -A
John is a 3-year-old who is scheduled to receive his first subQ injection of Neupogen. What
would NOT be an appropriate strategy to decrease the pain associated with a SC injection?
A. Use of ice and insuflon catheter
B. Use of LMX cream
C. Use of distraction
D. Use of buffered lidocaine - CORRECT ANSWER -D
The preferred intramuscular site for a child wo is three-years-old and walks is:
,A. Deltoid muscle
B. Vastus lateralis muscle
C. Ventogluteal muscle
D. Dorsogluteal muscle - CORRECT ANSWER -A
Which statement best describes the nursing assessment for patency with a direct-push method of
administering a chemotherapy vesicant:
A. Assess for blood return before the infusion, every 2-5ml, and for blood return and pain at the
end of the infusion
B. Assess for blood return before the infusion and at the completion of the infusion
C. Assess for blood return before the infusion and for pain at the completion of the infusion
D. Assess for blood return before infusion, every 5-10ml, during the infusion, and at the end of
the infusion - CORRECT ANSWER -A
A strategy to prevent chemo errors includes:
A. Verification of patient's height in inches
B. Independent dose calculation
C. Use of full trade name of the drug
D. Use of abbreviations for drug clarification - CORRECT ANSWER -B
Which chemo agent is associated with a maximum cumulative lifetime dose?
A. Cyclophosphamide
B. Etoposide
C. Daunorubicin
D. Nitrogen mustard - CORRECT ANSWER -C
, After administering the first drug for a dermatologiv reaction after peg-Asparaginase, Sam starts
to complain of throat tightening and he starts wheezing. The MD orders Epiniphrine. What is the
preferred route?
A. PO
B. Sub-Q
C. IV
D. IM - CORRECT ANSWER -D
You are giving Doxorubicin peripherally IV push and based on the patient's complaints and loss
of blood return, you suspect that the Doxorubicin has extravasated. Your immediate nursing
intervention will involve:
A. SLAPP: Stop the infusion, leave the needle, aspirate as much drug as possible, pull the
needle, provider notification
B. SLAPP: Slow the infusion, leave the needle, attempt to flush, push the remainder of the flush
into the vein, pull the needle
C. STOP: Stop the infusion, treat the site, oncology team notification, provide follow up
D. STOP: Slow the infusion, treat the symptoms, oncology team notification, provide follow up -
CORRECT ANSWER -A
The immediate temperature application for a Doxorubicin/Daunorubicin extravasation involves:
A. Hot application
B. Warm application
C. Cold application
D. None of the above - CORRECT ANSWER -C
The primary goal of phase III clinical trials is to determine:
